Structural modification of the tripeptide KPV by reductive "glycoalkylation" of the lysine residue.

ABSTRACT: Peptides that exhibit enzymatic or hormonal activities are regulatory factors and desirable therapeutic drugs because of their high target specificity and minimal side effects. Unfortunately, these drugs are susceptible to enzymatic degradation, leading to their rapid elimination and thereby demanding frequent dosage. Structurally modified forms of some peptide drugs have shown enhanced pharmacokinetics, improving their oral bioavailability. Here, we discuss a novel glycomimetic approach to modify lysine residues in peptides. In a model system, the ?-amine of Ts-Lys-OMe was reductively alkylated with a glucose derivative to afford a dihydroxylated piperidine in place of the amine. A similar modification was applied to H-KPV-NH2, a tripeptide derived from the ?-melanocyte stimulating hormone (?-MSH) reported to have antimicrobial and anti-inflammatory properties. Antimicrobial assays, under a variety of conditions, showed no activity for Ac-KPV-NH2 or the ?- or ?-glycoalkylated analogs. Glycoalkylated peptides did, however, show stability toward proteolytic enzymes.

SUBMITTER: Songok AC 

PROVIDER: S-EPMC6023233 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature